Yi Dan Zhu

Zhejiang Staidson Investment Co., Ltd. engages in investment industry. It services include Industrial Investment, Investment Management, Investment Consulting, and Business Management Consulting. The company was founded on June 27, 2017 and is headquartered in Zhejiang, China.

TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China.

1919 Wine & Spirits Platform Science & Technology Co., Ltd. operates an online to offline liquor business platform. Its business segments include supply chain system, control and supporting system, platform system, and business system. It offers wine, and other alcoholic products. The company was founded by LingJiang Yang in 1998 and is headquartered in Chengdu, China.

InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany.

University of Hong Kong School of Professional and Continuing Education engages in the educational services. It providing learning opportunities for personal, professional and career advancement for people from all walks of life. The company was founded in 1957 and is headquartered in Hong Kong.

Part of Staidson (Beijing) Biopharmaceuticals Co., Ltd., Staidson Hong Kong Investment Co. Ltd. provides asset management services. The company is based in Hong Kong, Hong Kong. Li Na Ma has been the CEO of the Chinese company since 2015.

Staidson Biopharma, Inc. is an American company that focuses on researching and developing biotechnology.

Hangzhou Jianjia Medical Technology Co., Ltd. principally engages in the research, development, production, and sale of surgical robots and related products. Its key products include hip and knee replacement surgery robots. The company was founded on December 12, 2018 and is headquartered in Hangzhou, China.